• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mRNA疫苗、腺病毒载体疫苗和蛋白质亚单位疫苗中抗SARS-CoV-2 IgG修饰及抗体功能的特定长期变化

Specific long-term changes in anti-SARS-CoV-2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines.

作者信息

Reinig Sebastian, Kuo Chin, Wu Chia-Chun, Huang Sheng-Yu, Yu Jau-Song, Shih Shin-Ru

机构信息

Research center for Emerging viral infections, Chang Gung University, Taoyuan, Taiwan.

Molecular research center, Chang Gung University, Taoyuan.

出版信息

medRxiv. 2024 Mar 14:2023.06.16.23291455. doi: 10.1101/2023.06.16.23291455.

DOI:10.1101/2023.06.16.23291455
PMID:38559243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10980124/
Abstract

Various vaccine platforms were developed and deployed against the COVID-19 disease. The Fc-mediated functions of IgG antibodies are essential in the adaptive immune response elicited by vaccines. However, the long-term changes of protein subunit vaccines and their combinations with mRNA vaccines are unknown. A total of 272 serum and plasma samples were collected from individuals who received first to third doses of the protein subunit Medigen, the mRNA (BNT), or the adenovector AstraZeneca vaccines. The IgG subclass level was measured using enzyme-linked immunosorbent assay, and Fc-N glycosylation was measured using LC-MS/MS. Antibody-dependent phagocytosis (ADCP) and complement deposition (ADCD) of anti-spike (S) IgG antibodies were measured. IgG1 and 3 reached the highest anti-S IgG subclass level. IgG1, 2, and 4 subclass levels significantly increased in mRNA- and Medigen-vaccinated individuals. Fc-glycosylation was stable, except in female BNT vaccinees, who showed increased bisection and decreased galactosylation. Female BNT vaccinees had a higher anti-S IgG titer than that of males. ADCP declined in all groups. ADCD increased in Medigen-vaccinated individuals after the third dose. Each vaccine produced specific long-term changes in Fc structure and function. This finding is critical when selecting a vaccine platform or combination to achieve the desired immune response.

摘要

针对新冠疾病研发并部署了多种疫苗平台。IgG抗体的Fc介导功能在疫苗引发的适应性免疫反应中至关重要。然而,蛋白质亚单位疫苗及其与mRNA疫苗联合使用后的长期变化尚不清楚。从接受了第一剂至第三剂蛋白质亚单位Medigen疫苗、mRNA(BNT)疫苗或腺载体阿斯利康疫苗的个体中总共收集了272份血清和血浆样本。使用酶联免疫吸附测定法测量IgG亚类水平,使用液相色谱-串联质谱法测量Fc-N糖基化。测量了抗刺突(S)IgG抗体的抗体依赖性吞噬作用(ADCP)和补体沉积(ADCD)。IgG1和IgG3达到了最高的抗S IgG亚类水平。在接种mRNA疫苗和Medigen疫苗的个体中,IgG1、IgG2和IgG4亚类水平显著升高。Fc糖基化是稳定的,除了接种BNT疫苗的女性,她们的平分糖基化增加而半乳糖基化减少。接种BNT疫苗的女性的抗S IgG滴度高于男性。所有组的ADCP均下降。接种Medigen疫苗的个体在第三剂后ADCD增加。每种疫苗在Fc结构和功能上都产生了特定的长期变化。在选择疫苗平台或组合以实现所需的免疫反应时,这一发现至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/d7b51f41cf08/nihpp-2023.06.16.23291455v3-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/cf0934c45a8a/nihpp-2023.06.16.23291455v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/20ae1f97a4f6/nihpp-2023.06.16.23291455v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/4110d1aefe54/nihpp-2023.06.16.23291455v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/fa2af6e327f1/nihpp-2023.06.16.23291455v3-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/d7b51f41cf08/nihpp-2023.06.16.23291455v3-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/cf0934c45a8a/nihpp-2023.06.16.23291455v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/20ae1f97a4f6/nihpp-2023.06.16.23291455v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/4110d1aefe54/nihpp-2023.06.16.23291455v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/fa2af6e327f1/nihpp-2023.06.16.23291455v3-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cdb/10980124/d7b51f41cf08/nihpp-2023.06.16.23291455v3-f0005.jpg

相似文献

1
Specific long-term changes in anti-SARS-CoV-2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines.mRNA疫苗、腺病毒载体疫苗和蛋白质亚单位疫苗中抗SARS-CoV-2 IgG修饰及抗体功能的特定长期变化
medRxiv. 2024 Mar 14:2023.06.16.23291455. doi: 10.1101/2023.06.16.23291455.
2
Specific long-term changes in anti-SARS-CoV-2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines.mRNA疫苗、腺病毒载体疫苗和蛋白质亚单位疫苗中抗SARS-CoV-2 IgG修饰及抗体功能的特定长期变化
J Med Virol. 2024 Jul;96(7):e29793. doi: 10.1002/jmv.29793.
3
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine.mRNA 疫苗针对 SARS-CoV-2 诱导的 IgG Fc 半乳糖基化和唾液酸化水平相比之下,腺病毒疫苗的水平较低,但长期 IgG4 反应会增加。
Front Immunol. 2023 Jan 12;13:1020844. doi: 10.3389/fimmu.2022.1020844. eCollection 2022.
4
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.在英国,使用不同的第三剂 COVID-19 疫苗接种方案进行同源和异源加强免疫后免疫应答的持久性:COV-BOOST 试验的 8 个月分析。
J Infect. 2023 Jul;87(1):18-26. doi: 10.1016/j.jinf.2023.04.012. Epub 2023 Apr 20.
5
Human IgG antibody responses to severe acute respiratory syndrome coronavirus 2 viral antigens receptor-binding domain, spike, and nucleocapsid, in vaccinated adults from Merida, Mexico.墨西哥梅里达接种疫苗的成年人对严重急性呼吸综合征冠状病毒2病毒抗原受体结合域、刺突蛋白和核衣壳的人IgG抗体反应。
Front Med (Lausanne). 2022 Jul 22;9:916241. doi: 10.3389/fmed.2022.916241. eCollection 2022.
6
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.在英国,两剂 ChAdOx1 nCov-19 或 BNT162b2 疫苗接种后,作为第三剂加强针接种 7 种 COVID-19 疫苗后免疫原性的持久性:COV-BOOST 试验的三个月分析。
J Infect. 2022 Jun;84(6):795-813. doi: 10.1016/j.jinf.2022.04.018. Epub 2022 Apr 9.
7
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
8
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.腺病毒、mRNA和蛋白质类SARS-CoV-2疫苗引发的刺突蛋白特异性IgG Fc糖蛋白谱的比较分析。
iScience. 2023 Aug 14;26(9):107619. doi: 10.1016/j.isci.2023.107619. eCollection 2023 Sep 15.
9
Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar.卡塔尔体力劳动者和手工艺工人人群中第二次接种新冠疫苗后抗S IgG抗体滴度的动态变化
Vaccines (Basel). 2023 Feb 21;11(3):496. doi: 10.3390/vaccines11030496.
10
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.COVID-19 严重程度与抗体 Fc 介导的固有免疫功能的差异有关。
mBio. 2021 Apr 20;12(2):e00281-21. doi: 10.1128/mBio.00281-21.

本文引用的文献

1
Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies.抗 SARS-CoV-2 IgG 抗体的非中和功能。
Biomed J. 2024 Feb;47(1):100666. doi: 10.1016/j.bj.2023.100666. Epub 2023 Sep 29.
2
Nonclinical safety assessment of an mRNA Covid-19 vaccine candidate following repeated administrations and biodistribution.一种新冠mRNA候选疫苗重复给药后的非临床安全性评估及生物分布
J Appl Toxicol. 2024 Mar;44(3):371-390. doi: 10.1002/jat.4548. Epub 2023 Sep 18.
3
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.
腺病毒、mRNA和蛋白质类SARS-CoV-2疫苗引发的刺突蛋白特异性IgG Fc糖蛋白谱的比较分析。
iScience. 2023 Aug 14;26(9):107619. doi: 10.1016/j.isci.2023.107619. eCollection 2023 Sep 15.
4
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history.SARS-CoV-2 mRNA 疫苗接种后针对刺突蛋白特异性 IgG4 抗体的类别转换取决于既往感染史。
Sci Rep. 2023 Aug 13;13(1):13166. doi: 10.1038/s41598-023-40103-x.
5
Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions.抗体Fc/Fc受体相互作用的选择性SARS-CoV-2 BA.2逃逸
iScience. 2023 May 19;26(5):106582. doi: 10.1016/j.isci.2023.106582. Epub 2023 Apr 7.
6
Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials.SARS-CoV-2 疫苗的有效性及其与三种主要抗体的剂量反应关系:一项随机对照试验的系统评价和荟萃分析。
Lancet Microbe. 2023 Apr;4(4):e236-e246. doi: 10.1016/S2666-5247(22)00390-1. Epub 2023 Feb 28.
7
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine.mRNA 疫苗针对 SARS-CoV-2 诱导的 IgG Fc 半乳糖基化和唾液酸化水平相比之下,腺病毒疫苗的水平较低,但长期 IgG4 反应会增加。
Front Immunol. 2023 Jan 12;13:1020844. doi: 10.3389/fimmu.2022.1020844. eCollection 2022.
8
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination.经重复 SARS-CoV-2 mRNA 疫苗接种后向非炎症性、刺突特异性 IgG4 抗体的类别转换。
Sci Immunol. 2023 Jan 27;8(79):eade2798. doi: 10.1126/sciimmunol.ade2798.
9
Neutralization of SARS-CoV-2 Omicron BA.1, BA.4, and BA.5 by primary ChAdOx1 nCoV-19, mRNA-1273, MVC-COV1901 and booster mRNA-1273 vaccination.ChAdOx1 nCoV-19初免、mRNA-1273、MVC-COV1901以及mRNA-1273加强免疫对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎BA.1、BA.4和BA.5的中和作用
Infection. 2023 Apr;51(2):531-534. doi: 10.1007/s15010-022-01922-8. Epub 2022 Sep 15.
10
Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines.影响 2019 冠状病毒病疫苗诱导中和抗体效价的因素。
Microbes Infect. 2023 Jan-Feb;25(1-2):105044. doi: 10.1016/j.micinf.2022.105044. Epub 2022 Sep 9.